Simon Chandler

Chief Executive Officer, Rinri Therapeutics

Simon has been Rinri’s CEO from its inception, working closely with Rinri’s founder and responsible for the strategic direction and operation of the company.

Having spent most of his career within blue-chip biotechnology and pharmaceutic companies, Simon has developed deep sector knowledge and experience in the biotech sector. He joined Rinri from IP Group, a specialist deep-tech venture capital fund, where he worked in early-stage investment and venture building, creating companies from world-class science. This exposed him to the innovative life science market across medical diagnostics, devices, synthetic biology, artificial intelligence, novel antimicrobials, and the advanced therapeutics landscape.

Simon believes that Rinri’s strong preclinical data and clinical development progress puts it at the forefront of hearing loss therapeutic development with enormous potential to make a real-world impact on patients and healthcare systems to realise a world where hearing loss can be restored, reconnecting people with the world around them.

He holds a 1st class BSc (Hons.) in Biology from the University of Leeds and a PhD. in Molecular Biology and Biochemistry from the University of York.

Stevenage Bioscience Catalyst

30 November 2023